Literature DB >> 23775670

Per-period co-payments and the demand for health care: evidence from survey and claims data.

Helmut Farbmacher1, Joachim Winter.   

Abstract

When health insurance reforms involve non-linear price schedules tied to payment periods (for example, fees levied by quarter or year), the empirical analysis of its effects has to take the within-period time structure of incentives into account. The analysis is further complicated when demand data are obtained from a survey in which the reporting period does not coincide with the payment period. We illustrate these issues using as an example a health care reform in Germany that imposed a per-quarter fee of €10 for doctor visits and additionally set an out-of-pocket maximum. This co-payment structure results in an effective 'spot' price for a doctor visit that decreases over time within each payment period. Taking this variation into account, we find a substantial reform effect-especially so for young adults. Overall, the number of doctor visits decreased by around 9% in the young population. The probability of visiting a physician in any given quarter decreased by around 4 to 8 percentage points.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  co-payments; health economics; natural experiment; non-linear pricing

Mesh:

Year:  2013        PMID: 23775670     DOI: 10.1002/hec.2955

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  3 in total

1.  Ex-post moral hazard in the health insurance market: empirical evidence from German data.

Authors:  Stefanie Thönnes
Journal:  Eur J Health Econ       Date:  2019-08-12

2.  Financial Catastrophism Inherent with Out-of-Pocket Payments in Long Term Care for Households: A Latent Impoverishment.

Authors:  Raúl Del Pozo-Rubio; Isabel Pardo-García; Francisco Escribano-Sotos
Journal:  Int J Environ Res Public Health       Date:  2020-01-01       Impact factor: 3.390

3.  Impact of the abolition of copayments on the GP-centred coordination of care in Bavaria, Germany: analysis of routinely collected claims data.

Authors:  Michaela Olm; Ewan Donnachie; Martin Tauscher; Roman Gerlach; Klaus Linde; Werner Maier; Lars Schwettmann; Antonius Schneider
Journal:  BMJ Open       Date:  2020-09-02       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.